Skip to main content
  • Saved

made a Post

Benign Presentation Following Massive Deutetrabenazine Overdose

Benign Presentation Following Massive Deutetrabenazine Overdose

Source :

https://www.cureus.com/articles/49130-benign-presentation-following-massive-deutetrabenazine-overdose

Deutetrabenazine (DTBZ) (Austedo®) is a novel vesicular monoamine transporter 2 (VMAT2) inhibitor, which acts by blocking dopamine release and other monoamines from neuronal vesicles. Although this drug is considered the first-line treatment for tardive dyskinesia (TD), VMAT2 inhibition has also been shown to improve patients' symptoms with Huntington's disease-induced chorea.